STING activator 2'3'-cGAMP enhanced HSV-1-based oncolytic viral therapy.
Sibal PA, Matsumura S, Ichinose T, Bustos-Villalobos I, Morimoto D, Eissa IR, Abdelmoneim M, Aboalela MAM, Mukoyama N, Tanaka M, Naoe Y, Kasuya H.
Sibal PA, et al. Among authors: eissa ir.
Mol Oncol. 2024 May;18(5):1259-1277. doi: 10.1002/1878-0261.13603. Epub 2024 Feb 23.
Mol Oncol. 2024.
PMID: 38400597
Free PMC article.